Saturday, September 30, 2006

FDA Drugs: Sept 2006

2007: Mar | Feb | Jan . . . 2006: Dec | Nov | Oct | Sep

Just a quick list of relevant FDA and related notices...

Lamictal & Pregnancy: cleft lip in first trimester... see also Neurology abstract reviewing risk of fetal abnormalities in 4 anticonvulsants (note: take numbers with grain of salt... the N for each drug exposure is kinda low)

Generic Topamax released

Effexor label revised: mentions risk of serotonin syndrome with triptans

Abilify 7.5mg injectable: approved for agitation associated with schizophrenia and bipolar disorder

Contrave advances: New obesity drug... combines Wellbutin/bupropion and Revia/naltrexone to cause weight loss... 6-month trial in 250 people results in 7.5% wt loss (vs 1% for placebo). [see also Orexigen site]

8 comments:

Sarebear said...

I cringe everytime I see that name, Abilify. Who thinks up these things? Lol.

Anonymous said...

Hmmm, on the Contrave, what are the doses used of the components? And where does one sign up?
--

Dinah said...

How come we don't do this every month??

Sarebear said...

It'd be cool if you did.

The Neurocritic said...
This comment has been removed by a blog administrator.
NeoNurseChic said...
This comment has been removed by the author.
The Neurocritic said...

Sorry! I thought you might write about [deleted comment] here. Didn't mean to offend.

Plus, the drug naming thing was kinda interesting, no?

Roy said...

Ok, so I'll try to do this more often. Pharmacology is my thing, so I'm glad to oblige.